Christopher Joseph Bettacchi MD

Physician

3409 Worth St Suite 710Dallas, TX 75246
Phone+1 214-823-2533
Fax+1 214-824-8679

Dr. Bettacchi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bettacchi's full profile Already have an account?

Education & Training

University of Alabama Hospital (Birmingham)Fellowship, Infectious Disease, 2008 - 2010
Loyola University Medical CenterResidency, Internal Medicine, 2001 - 2004
St. George's University School of MedicineClass of 2001

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TX State Medical License 2010 - 2028
AL State Medical License 2005 - 2010
VA State Medical License 2004 - 2006
IL State Medical License 2001 - 2005
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Vitera Intergy Meaningful Use Edition, Vitera Healthcare Solutions, LLC, 2012-2017
CMS Meaningful Use Stage 1 Certification Sage Intergy Meaningful Use Edition, Sage, 2012-2017
CMS Meaningful Use Stage 2 Certification Vitera Intergy Meaningful Use Edition, Vitera Healthcare Solutions, LLC, 2012-2017

Publications & Presentations

PubMed

Safety, Pharmacokinetics, and Pharmacodynamics of Single-Dose Programmed Cell Death Protein 1 Inhibitor, Budigalimab, in People With HIV-1 With Antiretroviral Therapy-...
Tanaya R Vaidya, Till Geib, Jacob P Lalezari, Christopher Bettacchi, Cynthia C Brinson
The Journal of Infectious Diseases. 2026-09-02
1 citations
Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results ...
Jürgen K Rockstroh, Sheetal Kassim, Roger Paredes, Christopher Bettacchi, Gary Sinclair
The Lancet. HIV. 2026-07-01
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir...
Amy E Colson, Anthony M Mills, Moti N Ramgopal, Christopher Bettacchi, Olayemi O Osiyemi
Lancet. 2026-02-07